Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Search research articles

Home
Individualized Prediction Of Overall Survival Time For Patients With Primary Intramedullary Spinal Cord Astrocytoma: A Population-based Study.

Home
Individualized Prediction Of Overall Survival Time For Patients With Primary Intramedullary Spinal Cord Astrocytoma: A Population-based Study.

Related Experiment Video

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Individualized Prediction of Overall Survival Time for Patients with Primary Intramedullary Spinal Cord Astrocytoma:

Yihao Li¹, Zezheng Zheng², Qiuju He³

¹Department of Neurosurgery, Tongde Hospital of Zhejiang Province, Hangzhou, China.

World Neurosurgery

|November 7, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Prognostic factors for primary intramedullary spinal cord astrocytoma (IMSCA) were identified, leading to a new predictive model. Lower tumor grade, younger age, and gross total resection improve survival for IMSCA patients.

Keywords:

Astrocytoma Intramedullary astrocytomas Nomogram Overall survival SEER

More Related Videos

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Experiment Videos

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

Neuro-oncology
Spinal cord tumors
Cancer epidemiology

Background:

Primary intramedullary spinal cord astrocytoma (IMSCA) is rare, with unclear prognostic factors.
Understanding these factors is crucial for improving patient outcomes.
This study aims to identify risk factors and develop a predictive model for IMSCA prognosis.

Purpose of the Study:

To identify independent risk factors influencing the prognosis of primary IMSCA.
To develop and visualize a prognostic nomogram for predicting overall survival in IMSCA patients.
To provide a tool for individualized survival predictions.

Main Methods:

Utilized the Surveillance, Epidemiology, and End Results (SEER) database (1975-2016) with 582 IMSCA patients.
Employed Kaplan-Meier, univariate, and multivariate Cox regression analyses.

Constructed and validated a prognostic nomogram using C-index, ROC curves, and calibration plots.

Main Results:

Tumor grade, age, and surgical approach were identified as independent prognostic factors.
The developed nomogram demonstrated good discriminative ability (C-index=0.764) and predictive accuracy.
Model validation confirmed its clinical utility for predicting 1-, 3-, and 10-year survival.

Conclusions:

Lower tumor grade, younger age, and gross total resection are protective factors for IMSCA prognosis.
Gender influences prognosis differently across tumor grades (II vs. III).
Radiation therapy may negatively impact survival in low-grade astrocytomas; chemotherapy showed no benefit. The developed nomogram is the first tool for individualized IMSCA prognosis.